Published in Arthritis Rheum on July 15, 2009
Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2010) 2.94
Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ (2013) 2.41
Uric acid transport and disease. J Clin Invest (2010) 2.33
A prospective controlled study of kidney donors: baseline and 6-month follow-up. Am J Kidney Dis (2013) 1.55
Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis (2014) 1.54
Longitudinal association between serum urate and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Intern Med (2013) 1.50
A prospective controlled study of living kidney donors: three-year follow-up. Am J Kidney Dis (2015) 1.48
Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study. J Am Coll Cardiol (2016) 1.46
High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr (2012) 1.43
Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study. Am J Med (2015) 1.42
A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol (2011) 1.40
Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease. PLoS One (2016) 1.39
Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed) (2012) 1.38
Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep (2013) 1.20
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol (2013) 1.15
Uric Acid and Cardiovascular Events: A Mendelian Randomization Study. J Am Soc Nephrol (2015) 1.08
Plasma uric acid concentrations and risk of ischaemic stroke in women. Eur J Neurol (2016) 1.07
The epidemiology of uric acid and fructose. Semin Nephrol (2011) 1.06
Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules. Proc Natl Acad Sci U S A (2013) 1.05
Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus. PLoS One (2011) 1.05
Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses. PLoS One (2013) 1.05
Severe cutaneous reactions requiring hospitalization in allopurinol initiators: a population-based cohort study. Arthritis Care Res (Hoboken) (2013) 1.03
Association of serum uric acid and incident nonspine fractures in elderly men: the Osteoporotic Fractures in Men (MrOS) study. J Bone Miner Res (2014) 0.97
Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study. BMC Cardiovasc Disord (2013) 0.97
Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study. Ann Rheum Dis (2011) 0.96
Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med (2013) 0.95
Interaction of inflammation, hyperuricemia, and the prevalence of hypertension among adults free of metabolic syndrome: NHANES 2009-2010. J Am Heart Assoc (2014) 0.94
Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study. Clin Exp Nephrol (2012) 0.91
Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis. Am J Cardiol (2012) 0.87
Dietary, anthropometric, and biochemical determinants of uric acid in free-living adults. Nutr J (2013) 0.85
Is there a link between hyperuricemia, morning blood pressure surge, and non-dipping blood pressure pattern in metabolic syndrome patients? Int J Nephrol Renovasc Dis (2013) 0.83
Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction. Arthritis Res Ther (2012) 0.83
Serum uric acid and subsequent cognitive performance in patients with pre-existing cardiovascular disease. PLoS One (2015) 0.83
Relationship between inflammatory cytokines and uric acid levels with adverse cardiovascular outcomes in patients with stable coronary heart disease. PLoS One (2012) 0.82
EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy. J Am Soc Nephrol (2015) 0.82
Comorbidities in patients with crystal diseases and hyperuricemia. Rheum Dis Clin North Am (2014) 0.81
Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am J Nephrol (2011) 0.80
Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims. Ann Rheum Dis (2015) 0.80
The potential role of sodium glucose co-transporter 2 inhibitors in the early treatment of type 2 diabetes mellitus. Int J Clin Pract (2015) 0.79
The cardiometabolic benefits of glycine: Is glycine an 'antidote' to dietary fructose? Open Heart (2014) 0.78
Risk of incident atrial fibrillation in gout: a cohort study. Ann Rheum Dis (2015) 0.78
Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study. Clin Exp Nephrol (2016) 0.77
Genetic variants of SLC17A1 are associated with cholesterol homeostasis and hyperhomocysteinaemia in Japanese men. Sci Rep (2015) 0.77
Family history of exceptional longevity is associated with lower serum uric acid levels in Ashkenazi Jews. J Am Geriatr Soc (2012) 0.77
Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.77
Hyperuricemia and incident cardiovascular disease and noncardiac vascular events in patients with rheumatoid arthritis. Int J Rheumatol (2014) 0.77
The association of uric acid with leukoaraiosis. J Int Med Res (2016) 0.77
Serum uric acid levels and mortality in the Japanese population: the Yamagata (Takahata) study. Clin Exp Nephrol (2016) 0.77
Asymptomatic hyperuricemia is independently associated with coronary artery calcification in the absence of overt coronary artery disease: A single-center cross-sectional study. Medicine (Baltimore) (2017) 0.76
Association between the hypertriglyceridemic waist phenotype and hyperuricemia: a cross-sectional study. Clin Rheumatol (2017) 0.76
Serum Urate and Incident Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. PLoS One (2015) 0.76
The association of albuminuria with tubular reabsorption of uric acid: results from a general population cohort. J Am Heart Assoc (2014) 0.76
Xanthine oxidase and uric Acid in atrial fibrillation. Front Physiol (2012) 0.76
Treatment of Thyroid Dysfunctions Decreases the Risk of Cerebrovascular Events in Men but Not in Women: Results of the MONICA/KORA Cohort Study. PLoS One (2016) 0.76
Potential causal associations between vitamin D and uric acid: Bidirectional mediation analysis. Sci Rep (2015) 0.76
The role of uric acid as a potential neuroprotectant in acute ischemic stroke: a review of literature. Neurol Sci (2015) 0.76
Association of serum uric acid and risk of hypertension in adults: a prospective study of Kailuan Corporation cohort. Clin Rheumatol (2017) 0.76
Hyperuricemia as a Potential Determinant of Metabolic Syndrome. J Lifestyle Med (2013) 0.75
Gender-related differences in the association between serum uric acid and left ventricular mass index in patients with obstructive hypertrophic cardiomyopathy. Biol Sex Differ (2016) 0.75
The Effects of Statins on Infections after Stroke or Transient Ischemic Attack: A Meta-Analysis. PLoS One (2015) 0.75
Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data. BMC Med (2017) 0.75
Serum uric acid levels and cardiovascular disease: the Gordian knot. J Thorac Dis (2016) 0.75
The Impacts of Serum Uric Acid on arterial hemodynamics and Cardiovascular Risks. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2013) 0.75
An Invert U-Shaped Curve: Relationship Between Fasting Plasma Glucose and Serum Uric Acid Concentration in a Large Health Check-Up Population in China. Medicine (Baltimore) (2016) 0.75
Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes. BMC Cardiovasc Disord (2017) 0.75
Cystatin C as a predictor of mortality and cardiovascular events in a population with chronic kidney disease. Int J Nephrol (2014) 0.75
Higher blood hematocrit predicts hyperuricemia: a prospective study of 62,897 person-years of follow-up. Sci Rep (2015) 0.75
Is urate crystal precipitation a predictor of cardiovascular risk in hyperuricemic patients? A Danish cohort study. Arthritis Res Ther (2015) 0.75
Lower serum uric acid level strongly predict short-term poor functional outcome in acute stroke with normoglycaemia: a cohort study in China. BMC Neurol (2017) 0.75
Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications. Ther Adv Musculoskelet Dis (2016) 0.75
Highly Prevalent Hyperuricaemia is Associated with Adverse Clinical Outcomes Among Ghanaian Stroke Patients: An Observational Prospective Study. Ghana Med J (2015) 0.75
Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study. BMC Cardiovasc Disord (2016) 0.75
Acute ischemic non-embolic stroke and serum level of uric acid. Iran J Neurol (2012) 0.75
Sex-Specific Relationship Between Serum Uric Acid and Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Studies. J Am Heart Assoc (2017) 0.75
[Crystal-induced activation of the inflammasome: gout and pseudogout]. Z Rheumatol (2009) 0.75
The management of gout in different clinical specialties in Turkey: a patient-based survey. Clin Rheumatol (2016) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2007) 22.81
Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol (2001) 12.72
Uric acid and cardiovascular risk. N Engl J Med (2008) 12.20
Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med (2005) 7.24
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA (2000) 6.10
Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA (2008) 5.59
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension (2003) 5.47
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
A role for uric acid in the progression of renal disease. J Am Soc Nephrol (2002) 3.77
Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension (2003) 3.39
Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol (2002) 3.37
Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol (2008) 3.12
Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med (2005) 2.98
Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke (2003) 2.96
Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke (2006) 2.63
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension (2000) 2.55
Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension (2002) 2.47
Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem (2007) 2.10
Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem (1991) 1.95
J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis (2006) 1.88
Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke (1998) 1.88
Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol (2000) 1.78
Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol (1996) 1.65
Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol (2002) 1.64
Solubility of uric acid and monosodium urate. Med Biol Eng (1972) 1.61
Uric acid: neuroprotective or neurotoxic? Stroke (2008) 1.56
Gout and hyperuricemia. Curr Opin Rheumatol (2002) 1.45
Hyperuricemia and associated diseases. Rheum Dis Clin North Am (2006) 1.37
Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol (2005) 1.33
Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant (2004) 1.33
Serum uric acid and target organ damage in primary hypertension. Hypertension (2005) 1.29
Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis (2005) 1.29
Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke (1985) 1.28
Serum uric acid and risk of ischemic stroke: the ARIC Study. Atherosclerosis (2005) 1.25
Urate and ascorbate: their possible roles as antioxidants in determining longevity of mammalian species. Arch Gerontol Geriatr (1984) 1.12
Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly. Eur J Epidemiol (2001) 1.10
Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men. Eur J Cardiovasc Prev Rehabil (2004) 1.07
Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National Integrated Projects for Prospective Observation of Non-communicable Diseases and its Trend in the Aged. Eur J Epidemiol (2001) 1.05
Serum uric acid shows a J-shaped trend with coronary mortality in non-insulin-dependent diabetic elderly people. The CArdiovascular STudy in the ELderly (CASTEL). Acta Diabetol (2007) 1.05
Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with Type 2 diabetes. Diabet Med (2004) 1.02
Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans? Int J Cardiol (1999) 1.01
Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed. Nephrology (Carlton) (2004) 1.00
Gout and mortality. Clin Exp Rheumatol (2008) 0.95
Serum uric acid and risk of coronary heart disease. Curr Pharm Des (2005) 0.95
Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial. Angiology (2007) 0.95
Determinants of femoral and carotid artery atherosclerosis. J Intern Med (1994) 0.92
Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes. Eur J Cardiovasc Prev Rehabil (2006) 0.92
Editorial comment--Elevated uric acid and ischemic stroke: accumulating evidence that it is injurious and not neuroprotective. Stroke (2003) 0.84
Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki. Hypertens Res (2007) 0.84
Association between uric acid and carotid atherosclerosis in elderly persons. Intern Med (2005) 0.83
Serum uric acid as a risk factor for stroke in a fishing village of rural southern Japan. Jpn Circ J (1982) 0.78
Hyperuricemia associated with hypertension. A 4-year follow-up study of hyperuricemic hypertensives. Jpn Circ J (1978) 0.77
Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum (2011) 6.36
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proc Natl Acad Sci U S A (2009) 5.36
Measuring agreement in medical informatics reliability studies. J Biomed Inform (2002) 5.00
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum (2008) 4.20
Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr (2009) 4.04
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum (2002) 3.55
Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum (2012) 3.51
Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum (2006) 3.26
Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. N Engl J Med (2012) 3.15
Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum (2003) 3.13
Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2010) 2.94
Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med (2010) 2.94
Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2008) 2.91
Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med (2007) 2.89
Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol (2010) 2.86
Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study. Ann Intern Med (2014) 2.76
The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol (2008) 2.60
Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation (2007) 2.58
Multiple imputation for model checking: completed-data plots with missing and latent data. Biometrics (2005) 2.44
Medicare coverage of tumor necrosis factor alpha inhibitors as an influence on physicians' prescribing behavior. Arch Intern Med (2006) 2.36
Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol (2010) 2.29
Methodologic challenges in studying risk factors for progression of knee osteoarthritis. Arthritis Care Res (Hoboken) (2010) 2.20
A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care (2006) 2.18
The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum (2007) 2.16
Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2011) 2.14
Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med (2002) 2.13
Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med (2012) 2.12
Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies. BMJ (2014) 2.06
Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension (2007) 2.05
Vitamin C intake and serum uric acid concentration in men. J Rheumatol (2008) 2.05
An index of local sensitivity to nonignorable drop-out in longitudinal modelling. Stat Med (2005) 2.00
Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects. J Rheumatol (2002) 1.98
Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol (2002) 1.93
Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. Arthritis Rheum (2003) 1.92
Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol (2009) 1.91
Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med (2002) 1.89
Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics (2011) 1.84
Menopause, postmenopausal hormone use and serum uric acid levels in US women--the Third National Health and Nutrition Examination Survey. Arthritis Res Ther (2008) 1.75
Safe and effective. Ophthalmology (2003) 1.73
Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol (2008) 1.69
Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis. J Clin Oncol (2002) 1.68
A predictive model for the detection of tumor lysis syndrome during AML induction therapy. Leuk Lymphoma (2006) 1.67
Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis (2012) 1.63
Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma. Cancer Biol Ther (2008) 1.58
Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann Intern Med (2006) 1.57
Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum (2002) 1.52
A simple local sensitivity analysis tool for nonignorable coarsening: application to dependent censoring. Biometrics (2006) 1.50
Cost-effectiveness analysis of the Lyme disease vaccine. Arthritis Rheum (2002) 1.48
The association between gout and nephrolithiasis in men: The Health Professionals' Follow-Up Study. Kidney Int (2003) 1.48
The genetics of hyperuricaemia and gout. Nat Rev Rheumatol (2012) 1.47
Human proline-rich nuclear receptor coregulatory protein 2 mediates an interaction between mRNA surveillance machinery and decapping complex. Mol Cell (2009) 1.47
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses. Clin Cancer Res (2007) 1.47
Commentary: effect of obesity on mortality: comment on article by Banack and Kaufman. Epidemiology (2014) 1.45
Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. J Clin Oncol (2002) 1.44
Methylphenidate and risk of serious cardiovascular events in adults. Am J Psychiatry (2012) 1.42
Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database. Pediatr Crit Care Med (2015) 1.41
Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours. Cancer Biol Ther (2010) 1.40
Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies. Cancer Biol Ther (2009) 1.40
Electronic health record-based decision support to improve asthma care: a cluster-randomized trial. Pediatrics (2010) 1.40
Reproducibility of the nicotine metabolite ratio in cigarette smokers. Cancer Epidemiol Biomarkers Prev (2012) 1.34
Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers. Clin Cancer Res (2008) 1.32
Modeling heaping in self-reported cigarette counts. Stat Med (2008) 1.29
Extracellular gelatinase of Enterococcus faecalis destroys a defense system in insect hemolymph and human serum. Infect Immun (2007) 1.28
Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther (2011) 1.26
Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann Rheum Dis (2010) 1.25
Impact of diabetes against the future risk of developing gout. Ann Rheum Dis (2010) 1.24
Contrasting parents' and pediatricians' perspectives on shared decision-making in ADHD. Pediatrics (2010) 1.23
Shared decision-making in pediatrics: a national perspective. Pediatrics (2010) 1.21
The lupus family registry and repository. Rheumatology (Oxford) (2010) 1.21
Staufen1-mediated mRNA decay functions in adipogenesis. Mol Cell (2012) 1.20
Nonpharmacological intervention for agitation in dementia: a systematic review and meta-analysis. Aging Ment Health (2009) 1.20
Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med (2007) 1.20
Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int (2003) 1.17
Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology (2010) 1.17
A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions. Mol Ther (2010) 1.15
Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Rheumatology (Oxford) (2013) 1.11
A Bayesian approach for unplanned sample sizes in phase II cancer clinical trials. Clin Trials (2012) 1.10
Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology (Oxford) (2012) 1.10
Management of aortic disease in Marfan Syndrome: a decision analysis. Arch Intern Med (2005) 1.08
Allopurinol and mortality in hyperuricaemic patients. Rheumatology (Oxford) (2009) 1.08
Hyaluronic acid injections relieve knee pain. J Fam Pract (2005) 1.08
Design and analysis of controlled trials in naturally clustered environments: implications for medical informatics. J Am Med Inform Assoc (2002) 1.07
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma. Am J Respir Crit Care Med (2011) 1.07
Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Res Treat (2010) 1.07
The epidemiology of uric acid and fructose. Semin Nephrol (2011) 1.06
Tetrandrine-induced cell cycle arrest and apoptosis in A549 human lung carcinoma cells. Int J Oncol (2002) 1.06
Selective translational repression of truncated proteins from frameshift mutation-derived mRNAs in tumors. PLoS Biol (2007) 1.04
Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide. Ann Rheum Dis (2011) 1.03
Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis (2009) 1.03
Sensitivity of the hazard ratio to nonignorable treatment assignment in an observational study. Stat Med (2007) 1.02
Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis. Am J Epidemiol (2012) 1.02
Shared decision-making and health care expenditures among children with special health care needs. Pediatrics (2011) 1.02
Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) (2011) 1.00
Household income and earnings losses among 6,396 persons with rheumatoid arthritis. J Rheumatol (2005) 1.00
Nonignorable censoring in randomized clinical trials. Clin Trials (2005) 0.99